Breaking news on colorectoral_cancer
Cancer Genomics: Special Issue Published By Genome Research published
Fri, 03 Feb 2012 01:00:00 PST
Genome Research publishes online and in print a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer...
Improved Detection Of Colorectal Cancer By Flexible Sigmoidoscopy published
Wed, 01 Feb 2012 01:00:00 PST
Repeated screening by flexible sigmoidoscopy (FSG) increased the detection of colorectal cancer or advanced adenoma in women by one-fourth and in men by one-third, according to a study published Jan. 31 in the Journal of the National Cancer Institute...
Alcohol Consumption And Risk Of Colon Cancer In People With A Family History Of Such Cancer published
Wed, 01 Feb 2012 00:00:00 PST
A study based on more than 87,000 women and 47,000 men in the Nurses' Health Study and the Health Professionals Follow-up Study, looks at whether there is a link between colon cancer and alcohol, and if so at what level of consumption, and the importance of a family history of the disease. A total of 1,801 cases of colon cancer were diagnosed during follow-up from 1980 onwards...
Immunological Mechanisms Of Oncolytic Adenoviral Therapy published
Tue, 31 Jan 2012 00:00:00 PST
Cancer is one of the most common causes of death in humans. The conventional cancer therapies include surgery, radiotherapy, chemotherapy, and targeting therapies, which are intended to directly destroy and eliminate tumor cells. These treatments often fail, resulting in tumor metastasis and recurrence. Therefore, there is a critical need for novel cancer therapies...
Researchers Discover New Therapeutic Target To Combat Liver Cancer published
Sat, 28 Jan 2012 00:00:00 PST
Researchers at CIC Biogune, the Cooperative Centre for Research into Biosciences and led by Dr. Maria Luz Martinez Chantar, have found a strong relationship between high levels of Hu antigen R (HuR) protein and the malignancy of Hepatocellular Carcinoma, through a novel molecular process in the investigation of this pathology and known as neddylation...
Cancer Screening Rates Low Among Ethnic Groups, USA published
Fri, 27 Jan 2012 10:00:00 PST
Not only are relatively few Americans screened for cancer, but there are considerable disparities between ethnic and racial groups in the country, says a new report issued by NCI (National Cancer Institute) and the CDCF (Centers for Disease Control and Prevention). The authors added that screening rates are especially low among Hispanic and Asian Americans...
Cocoa Could Prevent Intestinal Pathologies Such As Colon Cancer published
Thu, 26 Jan 2012 00:00:00 PST
A new study on living animals has shown for the first time that eating cocoa (the raw material in chocolate) can help to prevent intestinal complaints linked to oxidative stress, including colon carcinogenesis onset caused by chemical substances...
Oxaliplatin Improves Colon Cancer Survival Rates published
Wed, 25 Jan 2012 09:00:00 PST
An investigation published Jan. 20 in The Journal of the National Cancer Institute reveals that individuals in the general population with stage III colon cancer showed improved survival rates when they were administered with 5-fluorouracil (5FU), a commonly used cancer treatment, in combination with oxaliplatin. Colon cancer is one of the leading causes for illness and death worldwide...
Cell Death Induced In Colon Cancer Cells By Compounds In Mate Tea published
Wed, 25 Jan 2012 00:00:00 PST
Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties...
The Quality Of Colonoscopy Reporting And Performance Examined By Study published
Wed, 25 Jan 2012 00:00:00 PST
Researchers in the Netherlands assessed the quality of colonoscopy reporting in daily clinical practice and evaluated the quality of colonoscopy performance. They found that colonoscopy reporting varied significantly in clinical practice. Colonoscopy performance met the suggested standards, however, considerable variability between endoscopy departments was found...
Smokers Continue Habit After Being Diagnosed With Cancer published
Tue, 24 Jan 2012 10:00:00 PST
According to a study published January 23 online in Cancer, many smokers do not drop the habit after being diagnosed with colorectal or lung cancer. The study by Elyse R. Ph.D., M.P.H.and her team at Massachusetts General Hospital, Boston involved 3,063 patients with colorectal cancer and 2,456 with lung cancer. The patients were seen at the time of diagnosis, and also five months later...
After A Cancer Diagnosis, Many People Continue To Smoke published
Tue, 24 Jan 2012 04:00:00 PST
A new analysis has found that a substantial number of lung and colorectal cancer patients continue to smoke after being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study provides valuable information on which cancer patients might need help to quit smoking...
Colon Cancer Survival Improved With Use Of Oxaliplatin published
Mon, 23 Jan 2012 10:00:00 PST
In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage III, or node-positive disease...
Colon Cancer Patient Survival Improved By Oxaliplatin published
Mon, 23 Jan 2012 01:00:00 PST
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published in the Journal of the National Cancer Institute. Colon cancer is a leading global cause of both illness and death; with an estimated 101,340 cases among Americans in 2011...
A Cause Of Resistance To Colon Cancer Treatment Identified published
Mon, 23 Jan 2012 01:00:00 PST
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR...
Luteolin, A Plant Flavonoid, Blocks Cell Signaling Pathways In Colon Cancer Cells published
Mon, 23 Jan 2012 00:00:00 PST
Luteolin is a flavonoid commonly found in fruit and vegetables. This compound has been shown in laboratory conditions to have anti-inflammatory, anti-oxidant and anti-cancer properties but results from epidemiological studies have been less certain...
By Stifling Protective Genes, Inflammatory Mediator Promotes Colorectal Cancer published
Mon, 23 Jan 2012 00:00:00 PST
Chronic inflammation combines with DNA methylation, a process that shuts down cancer-fighting genes, to promote development of colorectal cancer, scientists at The University of Texas MD Anderson Cancer Center report today in the advance online publication of the journal Nature Medicine...
Regorafenib Does Well In Metastatic Colorectal Trial published
Fri, 20 Jan 2012 18:00:00 PST
The latest results on Bayer HealthCare's investigational compound regorafenib (BAY 73-4506) from the international, multicenter, randomized, double-blind, placebo-controlled Phase III CORRECT (Colorectal cancer treated with regorafenib or place after failure of standard therapy) trial have been announced by Bayer HealthCare...
For Early Detection Of Colorectal Cancer, New Test Offers Greater Accuracy published
Fri, 20 Jan 2012 01:00:00 PST
Results of two studies suggest that a new, investigational colorectal cancer screening test developed in a collaboration between Mayo Clinic and Exact Sciences Inc. of Madison, Wis., is highly accurate and significantly more sensitive than other noninvasive tests at detecting precancerous tumors (adenomas) and early-stage cancer...
New Advances Aimed At Improving Treatment, Prognosis And Detection Of GI Cancers: 2012 Gastroinstestinal Cancers Symposium published
Thu, 19 Jan 2012 01:00:00 PST
New research into the treatment, prognosis and early detection of gastrointestinal cancers was released in advance of the ninth annual Gastrointestinal Cancers Symposium being held January 19-21, 2012, at The Moscone West Building in San Francisco, Calif...
Successful Trial Shows Drug Improves Survival Of Colorectal Cancer Patients published
Thu, 19 Jan 2012 01:00:00 PST
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented at the Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in San Francisco by Mayo Clinic oncologist Axel Grothey, M.D...
New Drug For Advanced Colorectal Cancer Shows Promise In Trial published
Wed, 18 Jan 2012 03:00:00 PST
An experimental drug for advanced colorectal cancer that available treatments have failed to halt, has shown promise in a clinical trial, says Bayer HealthCare, the company that makes it. The results of the phase III trial show that compared to placebo, regorafenib slowed tumor growth and extended survival...
Jennerex Announces First Patient Treated In Phase 2a Clinical Trial Of JX-594 As A Neoadjuvant Therapy In Colorectal Cancer published
Sun, 01 Jan 2012 00:00:00 PST
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, announced that the first patient has been treated in a Phase 2a clinical trial of JX-594 as a neoadjuvant therapy in patients who are undergoing surgery to treat colorectal cancer that has spread to the liver...
Thousands Of Lives Could Be Saved By Simple Test To Help Diagnose Bowel And Pancreatic Cancer published
Mon, 26 Dec 2011 00:00:00 PST
A simple online calculator could offer family GPs a powerful new tool in tackling two of the most deadly forms of cancer, say researchers...
Reactivating Cell Death In Colorectal Cancers published
Sun, 18 Dec 2011 00:00:00 PST
The research team at Lyon has developed an animal model carrying a mutation of the DCC gene. Mice carrying the mutation develop tumours, because this gene can no longer induce the death of the cancer cells. This discovery could lead to the development of a new targeted cancer treatment that aims to reactivate the dying of cancer cells...
)
|
|
